Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heartbeam Inc (NQ: BEAT ) 2.950 +0.470 (+18.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Heartbeam Inc < Previous 1 2 3 4 5 6 Next > HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century December 08, 2022 The heart is one of the most essential organs that propel life by pumping blood throughout the body and supporting Via Spotlight Growth Topics Death Exposures Death BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Signs Agreement to Build Exclusive AIMIGo 12-Lead 3D VECG Device December 07, 2022 Via Investor Brand Network Topics Supply Chain Exposures Product Safety Supply Chain HeartBeam (NASDAQ: BEAT) Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device December 07, 2022 SANTA CLARA, Calif., December 07, 2022--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and Via Spotlight Growth Topics Supply Chain Exposures Product Safety Supply Chain New Research Finds Gaming Can Cause Fatal Arrhythmias October 19, 2022 Via Investor Brand Network Frequency of Bowel Movement Could Predict Heart Attack Risk October 04, 2022 Via Investor Brand Network HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device December 07, 2022 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Recognized for ‘Unique Approach to Heart Attack Diagnosis’ December 02, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer November 23, 2022 Via Investor Brand Network HeartBeam Inc. (NASDAQ: BEAT) Awarded Top Honors for Game-Changing Cardiovascular Tech Platform November 21, 2022 Via Investor Brand Network BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Growing Portfolio with Valuable New Patent November 16, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias November 16, 2022 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2022 Financial Report November 11, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety HeartBeam Reports Third Quarter 2022 Financial Results November 10, 2022 From HeartBeam, Inc. Via Business Wire Study Finds Covid-19 Spikes Linked to Increases in Heart Attacks November 02, 2022 Via Investor Brand Network Exposures COVID-19 Study Finds Smart Watches Can Accurately Detect Atrial Fibrillation October 26, 2022 Via Investor Brand Network BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 2022 Results Conference Call October 25, 2022 Via Investor Brand Network HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time October 25, 2022 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Patented Breakthrough Technology Poised to Disrupt ECG Patch Market October 21, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article October 17, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Participate at Upcoming LD Micro Main Event XV Conference October 13, 2022 Via Investor Brand Network HeartBeam to Present at LD Micro Main Event XV Conference October 13, 2022 From HeartBeam, Inc. Via Business Wire Study Finds Coffee Consumption Reduces Risk of Cardiac Problems October 12, 2022 Via Investor Brand Network BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Seasoned Veteran as New Chief Medical Officer October 11, 2022 Via Investor Brand Network HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer October 11, 2022 From HeartBeam, Inc. Via Business Wire CapitalGainsReport: Sector Spotlight Medical Monitoring Stocks. (BEAT, DXCM, WHSI, NMRD, GBS) October 11, 2022 Via AB Newswire BioMedNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’ October 10, 2022 Via Investor Brand Network Exposures Product Safety Beat Of Life Entertainment- A One Stop Solution For Internet Marketing October 08, 2022 Internet marketing is the solution for business development in the digitalization era. Via IssueWire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability October 06, 2022 Via Investor Brand Network HeartBeam (NASDAQ: BEAT) Unveils Cardiac Wearable Connectivity Feature that Can Turn Smartwatch Devices into Around-the-Clock Heart Monitoring Solutions October 06, 2022 HeartBeam, Inc. (NASDAQ: BEAT) is engaged as a cardiac technology company, which leverages its line of proprietary algorithms to help Via Spotlight Growth Topics Intellectual Property Exposures Intellectual Property HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution October 06, 2022 From HeartBeam, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.